Patents by Inventor Jeremy Baryza

Jeremy Baryza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipids, lipid compositions, and methods of using them
    Patent number: 9301923
    Abstract: Disclosed are formulation and optimization protocols for delivery of therapeutically effective amounts of biologically active agents to liver, tumors, and/or other cells or tissues. Also provided are compositions and uses for cationic lipid compounds of formula (I). The invention also relates to compositions and uses for stealth lipids of formula (XI). Also provided are processes for making such compounds, compositions, and formulations, plus methods and uses of such compounds, compositions, and formulations to deliver biologically active agents to cells and/or tissues.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: April 5, 2016
    Assignee: NOVARTIS AG
    Inventors: Jeremy Baryza, Keith Bowman, Andrew Geall, Tanzina Labonte, Cameron Lee, Chandra Vargeese, Laura West, Junping Zhao
  • LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM
    Publication number: 20140309277
    Abstract: Disclosed are formulation and optimization protocols for delivery of therapeutically effective amounts of biologically active agents to liver, tumors, and/or other cells or tissues. Also provided are compositions and uses for cationic lipid compounds of formula (I). The invention also relates to compositions and uses for stealth lipids of formula (XI). Also provided are processes for making such compounds, compositions, and formulations, plus methods and uses of such compounds, compositions, and formulations to deliver biologically active agents to cells and/or tissues.
    Type: Application
    Filed: March 4, 2014
    Publication date: October 16, 2014
    Applicant: NOVARTIS AG
    Inventors: Jeremy BARYZA, Keith BOWMAN, Andrew GEALL, Tanzina LABONTE, Cameron LEE, Chandra VARGEESE, Laura WEST, Junping ZHAO
  • LIPIDS, LIPID COMPOSITIONS, AND METHODS OF USING THEM
    Publication number: 20110200582
    Abstract: Disclosed are formulation and optimization protocols for delivery of therapeutically effective amounts of biologically active agents to liver, tumors, and/or other cells or tissues. Also provided are compositions and uses for cationic lipid compounds of formula (I). The invention also relates to compositions and uses for stealth lipids of formula (XI). Also provided are processes for making such compounds, compositions, and formulations, plus methods and uses of such compounds, compositions, and formulations to deliver biologically active agents to cells and/or tissues.
    Type: Application
    Filed: December 21, 2010
    Publication date: August 18, 2011
    Applicant: NOVARTIS AG
    Inventors: Jeremy BARYZA, Keith BOWMAN, Andrew GEALL, Tanzina LABONTE, Cameron LEE, Chandra VARGEESE, Laura WEST, Junping ZHAO
  • Sulfonamide substituted chroman derivatives
    Patent number: 6903218
    Abstract: This invention related to novel sulfonamide substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: June 7, 2005
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: Gaetan H. Ladouceur, Richard D. Connell, Jeremy Baryza, Ann-Marie Campbell, Timothy G. Lease, James H. Cook
  • 4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
    Publication number: 20050119489
    Abstract: Disclosed are 4-sulfide/sulfoxide/sulfonyl-1H-pyrazolyl derivative compounds of formulas (I) or (II): wherein the variables n, R, R1, R2, R3, R3?, R4, R4?, R5 and R6 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor.
    Type: Application
    Filed: December 28, 2002
    Publication date: June 2, 2005
    Inventors: Gaetan Ladouceur, Emil Velthuisen, Soongyu Choi, Zhonghua Zhang, Yamin Wang, Jeremy Baryza, Philip Coish, Roger Smith, Jinshan Chen
  • 1H-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
    Publication number: 20050119246
    Abstract: Disclosed are pyrazolyl derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formula (I) or (II): wherein the variables R, R1, R2, R5 and R6 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor.
    Type: Application
    Filed: December 28, 2002
    Publication date: June 2, 2005
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: Gaetan Ladouceur, Emil Velthuisen, Soongyu Choi, Yamin Wang, Jeremy Baryza, Philip Coish, William Bullock, Roger Smith, Jinshan Chen
  • Novel sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
    Publication number: 20040072843
    Abstract: This invention related to novel sulfonamide substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
    Type: Application
    Filed: September 19, 2003
    Publication date: April 15, 2004
    Inventors: Gaetan H. Ladouceur, Richard D. Connell, Jeremy Baryza, Ann-Marie Campbell, Timothy G. Lease, James H. Cook
  • Compounds useful for preparation of Beta-3 adrenoreceptor agonist
    Publication number: 20030073839
    Abstract: This invention related to novel sulfonamide substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
    Type: Application
    Filed: March 7, 2000
    Publication date: April 17, 2003
    Inventors: Gaetan H. Ladouceur, Richard D. Connell, Jeremy Baryza, Anne-Marie Campbell, Timothy G. Lease, James H. Cook
  • Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
    Patent number: 6469031
    Abstract: This invention is related to novel carboxyl substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: October 22, 2002
    Assignee: Bayer Corporation
    Inventors: Richard D. Connell, Timothy G. Lease, Jeremy Baryza
  • Sulfonamide substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
    Patent number: 6051586
    Abstract: This invention related to novel sulfonamide substituted chroman derivatives which are useful in the treatment of beta-3 receptor mediated conditions.
    Type: Grant
    Filed: November 23, 1998
    Date of Patent: April 18, 2000
    Assignee: Bayer Corporation
    Inventors: Gaetan H. Ladouceur, Richard D. Connell, Jeremy Baryza, Ann-Marie Campbell, Timothy G. Lease, James H. Cook